Structure

Physi-Chem Properties

Molecular Weight:  502.4
Volume:  551.77
LogP:  5.625
LogD:  4.985
LogS:  -4.985
# Rotatable Bonds:  3
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.409
Synthetic Accessibility Score:  4.966
Fsp3:  0.969
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.877
MDCK Permeability:  4.4253676605876535e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.336
30% Bioavailability (F30%):  0.809

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.139
Plasma Protein Binding (PPB):  91.03617095947266%
Volume Distribution (VD):  1.05
Pgp-substrate:  2.4147086143493652%

ADMET: Metabolism

CYP1A2-inhibitor:  0.016
CYP1A2-substrate:  0.115
CYP2C19-inhibitor:  0.033
CYP2C19-substrate:  0.919
CYP2C9-inhibitor:  0.144
CYP2C9-substrate:  0.16
CYP2D6-inhibitor:  0.01
CYP2D6-substrate:  0.274
CYP3A4-inhibitor:  0.266
CYP3A4-substrate:  0.465

ADMET: Excretion

Clearance (CL):  3.894
Half-life (T1/2):  0.106

ADMET: Toxicity

hERG Blockers:  0.564
Human Hepatotoxicity (H-HT):  0.192
Drug-inuced Liver Injury (DILI):  0.029
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.856
Maximum Recommended Daily Dose:  0.902
Skin Sensitization:  0.933
Carcinogencity:  0.022
Eye Corrosion:  0.967
Eye Irritation:  0.175
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC220379

Natural Product ID:  NPC220379
Common Name*:   3Beta-Acetoxy-15Alpha,22-Dihydroxyhopane
IUPAC Name:   [(3S,3aS,5S,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-5-hydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
Synonyms:  
Standard InCHIKey:  YVAGCSJSVHJSNX-CSTUNLOWSA-N
Standard InCHI:  InChI=1S/C32H54O4/c1-19(33)36-26-14-16-30(7)22(27(26,2)3)13-17-31(8)23(30)10-11-24-29(6)15-12-20(28(4,5)35)21(29)18-25(34)32(24,31)9/h20-26,34-35H,10-18H2,1-9H3/t20-,21-,22-,23+,24+,25-,26-,29-,30-,31+,32-/m0/s1
SMILES:  CC(=O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2CC[C@H]2[C@@]1(C)[C@@H](O)C[C@@H]1[C@]2(C)CC[C@@H]1C(O)(C)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1928584
PubChem CID:   57398931
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001823] Hopanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30117 Hypocrella Genus Clavicipitaceae Eukaryota n.a. mycelium n.a. PMID[21995505]
NPO33604 Hypocrella sp. BCC 14524 Species Clavicipitaceae Eukaryota n.a. The fungus used in this study was isolated from a scale insect collected in Nam Nao National Park, Phetcha Bun Province, Thailand n.a. PMID[21995505]
NPO30414 Moelleriella Genus Clavicipitaceae Eukaryota n.a. n.a. n.a. PMID[21995505]
NPO29992 Aschersonia Genus Clavicipitaceae Eukaryota n.a. n.a. n.a. PMID[21995505]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 12.5 ug.mL-1 PMID[454970]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC220379 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9733 High Similarity NPC73515
0.9459 High Similarity NPC212453
0.9079 High Similarity NPC471045
0.8987 High Similarity NPC477285
0.8987 High Similarity NPC111582
0.8974 High Similarity NPC190940
0.8961 High Similarity NPC476176
0.8904 High Similarity NPC192192
0.8861 High Similarity NPC60018
0.8861 High Similarity NPC202688
0.8861 High Similarity NPC154043
0.8861 High Similarity NPC477286
0.8861 High Similarity NPC286719
0.8846 High Similarity NPC261616
0.88 High Similarity NPC74639
0.8784 High Similarity NPC127094
0.8767 High Similarity NPC129829
0.8767 High Similarity NPC254037
0.8718 High Similarity NPC201276
0.8718 High Similarity NPC80891
0.8684 High Similarity NPC186851
0.8659 High Similarity NPC215968
0.8659 High Similarity NPC155531
0.8625 High Similarity NPC289486
0.8625 High Similarity NPC61107
0.859 High Similarity NPC324700
0.859 High Similarity NPC224802
0.859 High Similarity NPC80089
0.859 High Similarity NPC171426
0.859 High Similarity NPC34046
0.8537 High Similarity NPC266651
0.8533 High Similarity NPC157422
0.8533 High Similarity NPC470071
0.8533 High Similarity NPC187471
0.8533 High Similarity NPC252182
0.8533 High Similarity NPC100586
0.8533 High Similarity NPC109457
0.8533 High Similarity NPC1340
0.8519 High Similarity NPC5280
0.8514 High Similarity NPC66407
0.8493 Intermediate Similarity NPC48079
0.8481 Intermediate Similarity NPC477287
0.8462 Intermediate Similarity NPC143133
0.8462 Intermediate Similarity NPC171658
0.8462 Intermediate Similarity NPC298168
0.8434 Intermediate Similarity NPC103782
0.8434 Intermediate Similarity NPC114378
0.8434 Intermediate Similarity NPC477283
0.8434 Intermediate Similarity NPC168231
0.8415 Intermediate Similarity NPC471044
0.8415 Intermediate Similarity NPC473336
0.84 Intermediate Similarity NPC282454
0.8395 Intermediate Similarity NPC208912
0.8395 Intermediate Similarity NPC2096
0.8378 Intermediate Similarity NPC472741
0.8375 Intermediate Similarity NPC474714
0.8356 Intermediate Similarity NPC142712
0.8333 Intermediate Similarity NPC4209
0.8312 Intermediate Similarity NPC272359
0.8312 Intermediate Similarity NPC477508
0.8293 Intermediate Similarity NPC474284
0.8293 Intermediate Similarity NPC475820
0.8293 Intermediate Similarity NPC474346
0.8293 Intermediate Similarity NPC474253
0.8293 Intermediate Similarity NPC213737
0.8293 Intermediate Similarity NPC473742
0.8289 Intermediate Similarity NPC473279
0.8272 Intermediate Similarity NPC58631
0.8243 Intermediate Similarity NPC476928
0.8235 Intermediate Similarity NPC201607
0.8235 Intermediate Similarity NPC56777
0.8228 Intermediate Similarity NPC317913
0.8228 Intermediate Similarity NPC133596
0.8228 Intermediate Similarity NPC11907
0.8228 Intermediate Similarity NPC474574
0.8228 Intermediate Similarity NPC207010
0.8228 Intermediate Similarity NPC64081
0.8205 Intermediate Similarity NPC212733
0.8205 Intermediate Similarity NPC231680
0.8205 Intermediate Similarity NPC91387
0.8205 Intermediate Similarity NPC270306
0.8193 Intermediate Similarity NPC299963
0.8193 Intermediate Similarity NPC473299
0.8182 Intermediate Similarity NPC151214
0.8182 Intermediate Similarity NPC153719
0.8182 Intermediate Similarity NPC191915
0.8171 Intermediate Similarity NPC121121
0.8171 Intermediate Similarity NPC268040
0.8171 Intermediate Similarity NPC472504
0.8171 Intermediate Similarity NPC477284
0.8171 Intermediate Similarity NPC30583
0.8161 Intermediate Similarity NPC473066
0.8158 Intermediate Similarity NPC231945
0.8158 Intermediate Similarity NPC232925
0.8158 Intermediate Similarity NPC63588
0.8158 Intermediate Similarity NPC251201
0.8148 Intermediate Similarity NPC304194
0.8148 Intermediate Similarity NPC206735
0.8125 Intermediate Similarity NPC31031
0.8125 Intermediate Similarity NPC243594
0.8118 Intermediate Similarity NPC252714
0.809 Intermediate Similarity NPC94582
0.809 Intermediate Similarity NPC57964
0.8077 Intermediate Similarity NPC280026
0.8077 Intermediate Similarity NPC472945
0.8077 Intermediate Similarity NPC472944
0.8077 Intermediate Similarity NPC167702
0.8077 Intermediate Similarity NPC304499
0.8052 Intermediate Similarity NPC195530
0.8052 Intermediate Similarity NPC157777
0.8052 Intermediate Similarity NPC131506
0.8049 Intermediate Similarity NPC48756
0.8049 Intermediate Similarity NPC12933
0.8049 Intermediate Similarity NPC280781
0.8049 Intermediate Similarity NPC476071
0.8046 Intermediate Similarity NPC10274
0.8046 Intermediate Similarity NPC77756
0.8026 Intermediate Similarity NPC107919
0.8026 Intermediate Similarity NPC477820
0.8025 Intermediate Similarity NPC320144
0.8025 Intermediate Similarity NPC305835
0.8025 Intermediate Similarity NPC477282
0.8025 Intermediate Similarity NPC81074
0.8023 Intermediate Similarity NPC4309
0.8 Intermediate Similarity NPC238796
0.8 Intermediate Similarity NPC252056
0.8 Intermediate Similarity NPC23884
0.8 Intermediate Similarity NPC472272
0.8 Intermediate Similarity NPC237071
0.8 Intermediate Similarity NPC476233
0.8 Intermediate Similarity NPC203434
0.8 Intermediate Similarity NPC156377
0.7976 Intermediate Similarity NPC219535
0.7976 Intermediate Similarity NPC237938
0.7976 Intermediate Similarity NPC319909
0.7975 Intermediate Similarity NPC174964
0.7975 Intermediate Similarity NPC243027
0.7975 Intermediate Similarity NPC317242
0.7975 Intermediate Similarity NPC195155
0.7975 Intermediate Similarity NPC196136
0.7975 Intermediate Similarity NPC478105
0.7975 Intermediate Similarity NPC158208
0.7975 Intermediate Similarity NPC97534
0.7955 Intermediate Similarity NPC219516
0.7952 Intermediate Similarity NPC242771
0.7952 Intermediate Similarity NPC296734
0.7952 Intermediate Similarity NPC311642
0.7952 Intermediate Similarity NPC100366
0.7952 Intermediate Similarity NPC164289
0.7949 Intermediate Similarity NPC470610
0.7949 Intermediate Similarity NPC472341
0.7949 Intermediate Similarity NPC473238
0.7945 Intermediate Similarity NPC114891
0.7927 Intermediate Similarity NPC477851
0.7927 Intermediate Similarity NPC472943
0.7927 Intermediate Similarity NPC475456
0.7927 Intermediate Similarity NPC472951
0.7907 Intermediate Similarity NPC140446
0.7907 Intermediate Similarity NPC5943
0.7907 Intermediate Similarity NPC43912
0.7907 Intermediate Similarity NPC33768
0.7901 Intermediate Similarity NPC185465
0.7901 Intermediate Similarity NPC471769
0.7889 Intermediate Similarity NPC279974
0.7882 Intermediate Similarity NPC290612
0.7875 Intermediate Similarity NPC5767
0.7875 Intermediate Similarity NPC163597
0.7875 Intermediate Similarity NPC475742
0.7865 Intermediate Similarity NPC287118
0.7865 Intermediate Similarity NPC471902
0.7865 Intermediate Similarity NPC473690
0.7865 Intermediate Similarity NPC256104
0.7865 Intermediate Similarity NPC182740
0.7865 Intermediate Similarity NPC211845
0.7865 Intermediate Similarity NPC122083
0.7857 Intermediate Similarity NPC470070
0.7848 Intermediate Similarity NPC10476
0.7848 Intermediate Similarity NPC48795
0.7848 Intermediate Similarity NPC192501
0.7848 Intermediate Similarity NPC228994
0.7841 Intermediate Similarity NPC185529
0.7841 Intermediate Similarity NPC472146
0.7821 Intermediate Similarity NPC469940
0.7816 Intermediate Similarity NPC160304
0.7808 Intermediate Similarity NPC218585
0.7808 Intermediate Similarity NPC148174
0.7808 Intermediate Similarity NPC71460
0.7805 Intermediate Similarity NPC73013
0.7802 Intermediate Similarity NPC296936
0.7802 Intermediate Similarity NPC304899
0.7802 Intermediate Similarity NPC253115
0.7792 Intermediate Similarity NPC299948
0.7792 Intermediate Similarity NPC99264
0.7792 Intermediate Similarity NPC241085
0.7792 Intermediate Similarity NPC470830
0.7791 Intermediate Similarity NPC171698
0.7791 Intermediate Similarity NPC131365
0.7791 Intermediate Similarity NPC83242
0.7791 Intermediate Similarity NPC321340
0.7791 Intermediate Similarity NPC12774

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC220379 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.859 High Similarity NPD6114 Approved
0.859 High Similarity NPD6118 Approved
0.859 High Similarity NPD6115 Approved
0.859 High Similarity NPD6697 Approved
0.8333 Intermediate Similarity NPD6117 Approved
0.8228 Intermediate Similarity NPD6116 Phase 1
0.8077 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD8034 Phase 2
0.7753 Intermediate Similarity NPD8035 Phase 2
0.7711 Intermediate Similarity NPD6928 Phase 2
0.7674 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD3703 Phase 2
0.7468 Intermediate Similarity NPD4787 Phase 1
0.7342 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD3702 Approved
0.7215 Intermediate Similarity NPD5360 Phase 3
0.7215 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD5777 Approved
0.716 Intermediate Similarity NPD6081 Approved
0.7097 Intermediate Similarity NPD8171 Discontinued
0.7093 Intermediate Similarity NPD7525 Registered
0.7083 Intermediate Similarity NPD7638 Approved
0.7037 Intermediate Similarity NPD4244 Approved
0.7037 Intermediate Similarity NPD4789 Approved
0.7037 Intermediate Similarity NPD4245 Approved
0.701 Intermediate Similarity NPD7640 Approved
0.701 Intermediate Similarity NPD8418 Phase 2
0.701 Intermediate Similarity NPD7639 Approved
0.6962 Remote Similarity NPD4224 Phase 2
0.6914 Remote Similarity NPD3698 Phase 2
0.6869 Remote Similarity NPD7632 Discontinued
0.6842 Remote Similarity NPD7748 Approved
0.6835 Remote Similarity NPD3171 Clinical (unspecified phase)
0.6771 Remote Similarity NPD7991 Discontinued
0.6747 Remote Similarity NPD4758 Discontinued
0.6733 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5364 Discontinued
0.6667 Remote Similarity NPD3671 Phase 1
0.6633 Remote Similarity NPD7902 Approved
0.6632 Remote Similarity NPD7515 Phase 2
0.6591 Remote Similarity NPD7645 Phase 2
0.6562 Remote Similarity NPD6399 Phase 3
0.6542 Remote Similarity NPD8133 Approved
0.6526 Remote Similarity NPD6700 Approved
0.6526 Remote Similarity NPD6701 Clinical (unspecified phase)
0.6505 Remote Similarity NPD6675 Approved
0.6505 Remote Similarity NPD6402 Approved
0.6505 Remote Similarity NPD7128 Approved
0.6505 Remote Similarity NPD5739 Approved
0.6486 Remote Similarity NPD8294 Approved
0.6486 Remote Similarity NPD8377 Approved
0.6458 Remote Similarity NPD6703 Approved
0.6458 Remote Similarity NPD6702 Approved
0.6455 Remote Similarity NPD7327 Approved
0.6455 Remote Similarity NPD7328 Approved
0.6452 Remote Similarity NPD8308 Discontinued
0.6429 Remote Similarity NPD8378 Approved
0.6429 Remote Similarity NPD8033 Approved
0.6429 Remote Similarity NPD8296 Approved
0.6429 Remote Similarity NPD8380 Approved
0.6429 Remote Similarity NPD8379 Approved
0.6429 Remote Similarity NPD8335 Approved
0.6396 Remote Similarity NPD7516 Approved
0.6381 Remote Similarity NPD7320 Approved
0.6381 Remote Similarity NPD6899 Approved
0.6381 Remote Similarity NPD6881 Approved
0.6355 Remote Similarity NPD8130 Phase 1
0.6327 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6327 Remote Similarity NPD7900 Approved
0.6322 Remote Similarity NPD6942 Approved
0.6322 Remote Similarity NPD7339 Approved
0.6321 Remote Similarity NPD6373 Approved
0.6321 Remote Similarity NPD6372 Approved
0.6304 Remote Similarity NPD6695 Phase 3
0.6304 Remote Similarity NPD3670 Clinical (unspecified phase)
0.6304 Remote Similarity NPD4788 Approved
0.6304 Remote Similarity NPD3669 Approved
0.63 Remote Similarity NPD6083 Phase 2
0.63 Remote Similarity NPD6084 Phase 2
0.6296 Remote Similarity NPD8297 Approved
0.6296 Remote Similarity NPD371 Approved
0.6286 Remote Similarity NPD5697 Approved
0.6286 Remote Similarity NPD7646 Clinical (unspecified phase)
0.6286 Remote Similarity NPD5701 Approved
0.6273 Remote Similarity NPD6940 Discontinued
0.6262 Remote Similarity NPD7290 Approved
0.6262 Remote Similarity NPD7102 Approved
0.6262 Remote Similarity NPD6883 Approved
0.625 Remote Similarity NPD6051 Approved
0.625 Remote Similarity NPD5328 Approved
0.6237 Remote Similarity NPD4786 Approved
0.6237 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6226 Remote Similarity NPD6011 Approved
0.6211 Remote Similarity NPD7750 Discontinued
0.6207 Remote Similarity NPD1811 Approved
0.6207 Remote Similarity NPD1810 Approved
0.6204 Remote Similarity NPD6649 Approved
0.6204 Remote Similarity NPD6869 Approved
0.6204 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6204 Remote Similarity NPD6847 Approved
0.6204 Remote Similarity NPD6617 Approved
0.6204 Remote Similarity NPD6650 Approved
0.619 Remote Similarity NPD6920 Discontinued
0.619 Remote Similarity NPD6705 Phase 1
0.6168 Remote Similarity NPD6014 Approved
0.6168 Remote Similarity NPD6012 Approved
0.6168 Remote Similarity NPD6013 Approved
0.6168 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6154 Remote Similarity NPD4748 Discontinued
0.6147 Remote Similarity NPD6882 Approved
0.6146 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6122 Remote Similarity NPD6079 Approved
0.6122 Remote Similarity NPD7637 Suspended
0.6117 Remote Similarity NPD1700 Approved
0.6105 Remote Similarity NPD3618 Phase 1
0.6102 Remote Similarity NPD7736 Approved
0.6091 Remote Similarity NPD8298 Phase 2
0.6091 Remote Similarity NPD4632 Approved
0.6075 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6071 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6071 Remote Similarity NPD7115 Discovery
0.6068 Remote Similarity NPD7507 Approved
0.6067 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6061 Remote Similarity NPD4202 Approved
0.6047 Remote Similarity NPD7532 Clinical (unspecified phase)
0.6042 Remote Similarity NPD7524 Approved
0.6042 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6038 Remote Similarity NPD6008 Approved
0.6023 Remote Similarity NPD6924 Approved
0.6023 Remote Similarity NPD6926 Approved
0.6022 Remote Similarity NPD3667 Approved
0.6019 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6 Remote Similarity NPD7911 Approved
0.6 Remote Similarity NPD7503 Approved
0.6 Remote Similarity NPD7912 Approved
0.6 Remote Similarity NPD7986 Approved
0.6 Remote Similarity NPD3198 Approved
0.6 Remote Similarity NPD7987 Approved
0.5982 Remote Similarity NPD7755 Approved
0.5982 Remote Similarity NPD7754 Approved
0.598 Remote Similarity NPD4755 Approved
0.598 Remote Similarity NPD7919 Phase 3
0.598 Remote Similarity NPD7920 Phase 3
0.5979 Remote Similarity NPD6672 Approved
0.5979 Remote Similarity NPD5737 Approved
0.5978 Remote Similarity NPD6931 Approved
0.5978 Remote Similarity NPD6930 Phase 2
0.5941 Remote Similarity NPD6356 Clinical (unspecified phase)
0.5941 Remote Similarity NPD5695 Phase 3
0.5938 Remote Similarity NPD7146 Approved
0.5938 Remote Similarity NPD7521 Approved
0.5938 Remote Similarity NPD6409 Approved
0.5938 Remote Similarity NPD5330 Approved
0.5938 Remote Similarity NPD6684 Approved
0.5938 Remote Similarity NPD7334 Approved
0.5934 Remote Similarity NPD4802 Phase 2
0.5934 Remote Similarity NPD4238 Approved
0.5929 Remote Similarity NPD6009 Approved
0.5922 Remote Similarity NPD8088 Phase 1
0.5922 Remote Similarity NPD5696 Approved
0.5917 Remote Similarity NPD7319 Approved
0.5913 Remote Similarity NPD6319 Approved
0.5897 Remote Similarity NPD7604 Phase 2
0.589 Remote Similarity NPD385 Approved
0.589 Remote Similarity NPD384 Approved
0.5889 Remote Similarity NPD6933 Approved
0.5888 Remote Similarity NPD8040 Discontinued
0.5882 Remote Similarity NPD5220 Clinical (unspecified phase)
0.5882 Remote Similarity NPD4697 Phase 3
0.5882 Remote Similarity NPD5221 Approved
0.5882 Remote Similarity NPD5222 Approved
0.5882 Remote Similarity NPD8293 Discontinued
0.5877 Remote Similarity NPD6335 Approved
0.587 Remote Similarity NPD6929 Approved
0.5865 Remote Similarity NPD5285 Approved
0.5865 Remote Similarity NPD4700 Approved
0.5865 Remote Similarity NPD4696 Approved
0.5865 Remote Similarity NPD5286 Approved
0.5862 Remote Similarity NPD2686 Approved
0.5862 Remote Similarity NPD2687 Approved
0.5862 Remote Similarity NPD2254 Approved
0.5862 Remote Similarity NPD5983 Phase 2
0.5847 Remote Similarity NPD7492 Approved
0.5841 Remote Similarity NPD6274 Approved
0.5841 Remote Similarity NPD6868 Approved
0.5833 Remote Similarity NPD7990 Approved
0.5833 Remote Similarity NPD6412 Phase 2
0.5833 Remote Similarity NPD7989 Approved
0.5826 Remote Similarity NPD7101 Approved
0.5826 Remote Similarity NPD7100 Approved
0.5825 Remote Similarity NPD5173 Approved
0.5824 Remote Similarity NPD8143 Approved
0.5824 Remote Similarity NPD8144 Approved
0.5824 Remote Similarity NPD6932 Approved
0.5818 Remote Similarity NPD5955 Clinical (unspecified phase)
0.5816 Remote Similarity NPD6903 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data